Novavax’s COVID-19 vaccine could soon receive full approval from the United States Food and Drug Administration.

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

Novavax said Monday morning that the Food and Drug Administration was asking the company to run a new trial of its Covid-19 ...

WASHINGTON — Novavax's closely watched COVID-19 vaccine is on track for full approval after additional discussions with the ...

Chris Smith has been covering consumer electronics ever since the iPhone revolutionized the industry in 2007. When he’s not writing about the most recent tech news for BGR, he closely follows the ...

As in previous studies, the SHIELD study found health care workers who received the Novavax vaccine reported significantly fewer reactogenicity events than Pfizer-BioNTech recipients. On average ...

Preliminary data showed Novavax's non-mRNA JN.1 COVID-19 vaccine induced lower frequency and severity of short-term side effects and impact on daily life compared with Pfizer-BioNTech mRNA vaccine ...

Novavax (NVAX) announced preliminary results from the SHIELD-Utah study that showed Novavax’s COVID-19 Vaccine, Adjuvanted 2024-2025 Formula ...

2.8) and a lower impact on daily activities than those who received the Pfizer-BioNTech mRNA vaccine. This development comes as Novavax maintains a solid financial position with more cash than ...